枸橼酸抗凝在重症患者连续血液净化中的应用进展

Abstract
Figure/Table
References
Related Citation (15)

[1]	Canaud B,Cohen E P.Initiation of renal-replacement therapy in the intensive care unit[J].N Engl J Med,2016,375(19):1901.
[2]	Brandenburger T,Dimski T,Slowinski T,et al.Renal replacement therapy and anticoagulation[J].Best Pract Res Clin Anaesthesiol,2017,31(3):387-401.
[3]	张鑫,张文博,李莹,等.连续性血液净化中阿加曲班与枸橼酸钠的抗凝效果及安全性比较[J].武警医学,2020,31(2):103-106.
[4]	Khwaja A.KDIGO clinical practice guidelines for acute kidney injury[J].Nephron Clin Pract,2012,120(4):c179-c184.
[5]	刘娜娜.局部枸橼酸抗凝用于重症患者血液净化的研究进展[J].天津医科大学学报,2019,25(1):90-93.
[6]	Poh C B,Tan P C,Kam J W,et al.Regional citrate anticoagulation for continuous renal replacement therapy-a safe and effective low-dose protocol[J].Nephrology (Carlton),2020,25(4):305-313.
[7]	Mehta R L,McDonald B R,Aguilar M M,et al.Regional citrate anticoagulation for continuous arteriovenous hemodialysis in critically ill patients[J].Kidney Int,1990,38(5):976-981.
[8]	Liu C,Mao Z,Kang H,et al.Regional citrate versus heparin anticoagulation for continuous renal replacement therapy in critically ill patients:a meta-analysis with trial sequential analysis of randomized controlled trials[J].Crit Care,2016,20(1):144.
[9]	Slowinski T,Morgera S,Joannidis M,et al.Safety and efficacy of regional citrate anticoagulation in continuous venovenous hemodialysis in the presence of liver failure:the Liver Citrate Anticoagulation Threshold (L-CAT) observational study[J].Crit Care,2015,19:349.
[10]	Ricci D,Panicali L,Facchini M G,et al.Citrate anticoagulation during continuous renal replacement therapy[J].Contrib Nephrol,2017,190:19-30.
[11]	卜春红,陈琳光,郑国利.局部枸橼酸抗凝在连续性肾替代疗法治疗中的效果研究[J].中国临床药理学杂志,2020,36(6):602-605.
[12]	Faguer S,Saint C M,Nogier M B,et al.Heparin-free prolonged intermittent hemodialysis using calcium-free citrate dialysate in critically ill patients[J].Crit Care Med,2017,45(11):1887-1892.
[13]	Jaillette E,Girault C,Brunin G,et al.French intensive care society,international congress-réanimation 2016[J].Ann Intensive Care,2016,6(Suppl 1):50.
[14]	刘焕皓,覃英镨,喻小清.含钙透析液联合枸橼酸与无钙透析液联合枸橼酸抗凝在高危出血患者血液透析中的应用对比观察[J].中国临床医生杂志,2018,46(8):926-928.
[15]	罗冰,熊明媚,黄东健.枸橼酸钠置换液在血液滤过中的抗凝效果评估[J].热带医学杂志,2009,9(8):908-910,907.
[16]	Meulen K J,Dekker M J,Pasch A,et al.Citric-acid dialysate improves the calcification propensity of hemodialysis patients:a multicenter prospective randomized cross-over trial[J].PLoS One,2019,14(12):e0225824.
[17]	Molina N M,Alarcón R,Roca S,et al.Citrate versus acetate-based dialysate in on-line haemodiafiltration.a prospective cross-over study[J].Blood Purif,2015,39(1-3):181-187.
[18]	Monchi M,Berghmans D,Ledoux D,et al.Citrate vs.heparin for anticoagulation in continuous venovenous hemofiltration:a prospective randomized study[J].Intensive Care Med,2004,30(2):260-265.
[19]	Oudemans S M.Citrate anticoagulation for continuous renal replacement therapy in the critically ill[J].Blood Purif,2010,29(2):191-196.
[20]	Huguet M,Rodas L,Blasco M,et al.Clinical impact of regional citrate anticoagulation in continuous renal replacement therapy in critically ill patients[J].Int J Artif Organs,2017,40(12):676-682.
[21]	郑丽环,焦清海,李丹.局部枸橼酸抗凝在危重患者血液净化中的应用[J].临床误诊误治,2020,33(1):104-108.
[22]	Degraeve A,Danse E,Laterre P F,et al.Regional citrate anticoagulation and influence of recirculation on ionized calcium levels in the circuit[J].J Artif Organs,2019,22(4):341-344.
[23]	Klingele M,Seiler S,Poppleton A,et al.The gap between calculated and actual calcium substitution during citrate anticoagulation in an immobilised patient on renal replacement therapy reflects the extent of bone loss-a case report[J].BMC Nephrol,2014,15:163.
[24]	Strobl K,Harm S,Weber V,et al.The role of ionized calcium and magnesium in regional citrate anticoagulation and its impact on inflammatory parameters[J].Int J Artif Organs,2017,40(1):15-21.
[25]	Klingele M,Stadler T,Fliser D,et al.Long-term continuous renal replacement therapy and anticoagulation with citrate in critically ill patients with severe liver dysfunction[J].Crit Care,2017,21(1):294.
[26]	Tan J N,Haroon S W P,Mukhopadhyay A,et al.Hyperlactatemia predicts citrate intolerance with regional citrate anticoagulation during continuous renal replacement therapy[J].J Intensive Care Med,2019,34(5):418-425.
[27]	宁琪琪,高原,段美丽,等.局部枸橼酸抗凝在接受连续性肾脏替代治疗的肝病合并急性肾损伤中的应用效果观察[J].临床肝胆病杂志,2020,36(5):1055-1058.
[28]	Kindgen-Milles D,Brandenburger T,Dimski T.Regional citrate anticoagulation for continuous renal replacement therapy[J].Curr Opin Crit Care,2018,24(6):450-454.
[29]	Schultheiβ C,Saugel B,Phillip V,et al.Continuous venovenous hemodialysis with regional citrate anticoagulation in patients with liver failure:a prospective observational study[J].Crit Care,2012,16(4):R162.
[30]	马元吉,白浪,唐红.局部枸橼酸抗凝在人工肝治疗肝衰竭中的应用研究进展[J].中华肝脏病杂志,2020,28(6):532-535.
[31]	Mariano F,Tedeschi L,Morselli M,et al.Normal citratemia and metabolic tolerance of citrate anticoagulation for hemodiafiltration in severe septic shock burn patients[J].Intensive Care Med,2010,36(10):1735-1743.
[32]	Meier-Kriesche H U,Gitomer J,Finkel K,et al.Increased total to ionized calcium ratio during continuous venovenous hemodialysis with regional citrate anticoagulation[J].Crit Care Med,2001,29(4):748-752.
[33]	Zhang W,Bai M,Yu Y,et al.Safety and efficacy of regional citrate anticoagulation for continuous renal replacement therapy in liver failure patients:a systematic review and meta-analysis[J].Crit Care,2019,23(1):22.
[34]	苏盛元.枸橼酸局部抗凝在危重患者血液滤过中的应用[J].中国急救医学,2016,36(8):754-757.